Skin cancer prevention by oral nicotinamide [ 2012 - 2015 ]

Research Grant

Researchers: Prof Diona Damian (Principal investigator) ,  A/Pr Pablo Fernandez Peñas ,  Dr Andrew Martin ,  Prof Gary Halliday

Brief description Skin cancer affects 60% of Australians. Nicotinamide (vitamin B3) prevents many of sunlight’s damaging effects and reduces premalignant keratoses by 35% compared to placebo in sun-damaged individuals. We now need to test whether nicotinamide can prevent skin cancer. Skin cancer patients will receive nicotinamide or placebo for 12 months and new cancers will be counted in each group. Nicotinamide is safe, widely available and an exciting opportunity for cost-effective skin cancer prevention.

Funding Amount $AUD 607,331.59

Funding Scheme Project Grants

Notes Standard Project Grant